BlackRock Institutional Trust’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $17M | Buy |
1,963,062
+22,509
| +1% | +$194K | ﹤0.01% | 2080 |
|
|
2016
Q3 | $12.3M | Buy |
1,940,553
+163,595
| +9% | +$1.04M | ﹤0.01% | 2214 |
|
|
2016
Q2 | $7.5M | Sell |
1,776,958
-17,317
| -1% | -$73.1K | ﹤0.01% | 2462 |
|
|
2016
Q1 | $7.82M | Buy |
1,794,275
+7,853
| +0.4% | +$34.2K | ﹤0.01% | 2422 |
|
|
2015
Q4 | $11M | Sell |
1,786,422
-37,167
| -2% | -$228K | ﹤0.01% | 2260 |
|
|
2015
Q3 | $10.4M | Sell |
1,823,589
-209,436
| -10% | -$1.2M | ﹤0.01% | 2271 |
|
|
2015
Q2 | $15.2M | Sell |
2,033,025
-47,517
| -2% | -$354K | ﹤0.01% | 2106 |
|
|
2015
Q1 | $12.4M | Buy |
2,080,542
+7,881
| +0.4% | +$47.1K | ﹤0.01% | 2250 |
|
|
2014
Q4 | $15.7M | Sell |
2,072,661
-265,000
| -11% | -$2M | ﹤0.01% | 2065 |
|
|
2014
Q3 | $12.1M | Sell |
2,337,661
-62,487
| -3% | -$324K | ﹤0.01% | 2202 |
|
|
2014
Q2 | $10.3M | Buy |
2,400,148
+34,784
| +1% | +$150K | ﹤0.01% | 2414 |
|
|
2014
Q1 | $9.67M | Buy |
2,365,364
+444,873
| +23% | +$1.82M | ﹤0.01% | 2444 |
|
|
2013
Q4 | $10.2M | Buy |
1,920,491
+114,923
| +6% | +$613K | ﹤0.01% | 2405 |
|
|
2013
Q3 | $9.06M | Buy |
1,805,568
+312,557
| +21% | +$1.57M | ﹤0.01% | 2421 |
|
|
2013
Q2 | $6.66M | Buy |
+1,493,011
| New | +$6.66M | ﹤0.01% | 2551 |
|